Showing results (111-120 of 594) with videos related to
Sort By:
Pageof 60
Journal of Medicinal Chemistry|April 19, 2021
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2Wenhao Dai, Dirk Jochmans, Hang Xie, et al.Antiviral Research|June 17, 2017
Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1Alba Gigante, Asier Gómez-SanJuan, Leen Delang, et al.Biochemical Pharmacology|September 6, 2011
Combating enterovirus replication: state-of-the-art on antiviral researchHendrik Jan Thibaut, Armando M De Palma, Johan NeytsJournal of Medical Virology|December 26, 2003
Inhibition of coxsackie B3 virus induced myocarditis in mice by 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrileElizaveta Padalko, Erik Verbeken, Erik De Clercq, et al.Journal of Virology|January 15, 2005
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenasePieter Leyssen, Jan Balzarini, Erik De Clercq, et al.Antiviral Research|July 6, 2013
The potential of antiviral agents to control classical swine fever: a modelling studyJantien A Backer, Robert Vrancken, Johan Neyts, et al.Reviews in Medical Virology|October 30, 2007
Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the futureGeoffrey Férir, Suzanne Kaptein, Johan Neyts, et al.Viruses|October 14, 2011
Antiviral treatment of chronic hepatitis B virus (HBV) infectionsErik De Clercq, Geoffrey Férir, Suzanne Kaptein, et al.Antiviral Research|August 24, 2004
Rodent models for the study of therapy against flavivirus infectionsNathalie Charlier, Pieter Leyssen, Erik De Clercq, et al.Antimicrobial Agents and Chemotherapy|May 25, 2004
Efficacy of cidofovir in a murine model of disseminated progressive vacciniaJohan Neyts, Pieter Leyssen, Erik Verbeken, et al.Pageof 60